JBI CME Volume 4, Issue 3 Educational Review

Title of Activity: JBI CME Volume 4, Issue 3 Educational Review

Article: MRI in the Setting of Neoadjuvant Treatment of Breast Cancer

Author: Cecilia Mercado, MD

Learning Objectives:

1. Select the most appropriate treatment therapies for advanced breast cancer.
2. Describe the best imaging modality to predict pathologic complete response and recurrence free survival post neoadjuvant chemotherapy.
3. Identify the imaging modality that has the greatest pitfalls for predicting residual disease in patients with pathologic complete response.
4. Recognize the sensitivity and specificity of MRI in patients with no residual invasive tumor on pathology following neoadjuvant chemotherapy.

Date(s) of Activity: CE Release Date: September 16, 2022 – CE Expiration Date: September 16, 2025

Physician Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The American College of Radiology and the Society of Breast Imaging. The American College of Radiology is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation Statement: The American College of Radiology designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions to Receive Credit: In order to successfully complete the activity, participants must complete the post-test with a passing score of 80% or higher. A maximum of 3 attempts will be allowed. Upon successful completion of the post-test, participants must complete an activity evaluation and claim credit commensurate with their participation in the activity.

Contact Information: For information about the accreditation of this program, please contact SBI at info@sbi-online.org.

Disclosure of Relevant Financial Relationships

The ACR Disclosure Policy: The American College of Radiology (ACR) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ACR are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by ACR in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ACR to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ACR.

The following planners and managers have no relevant financial relationships to disclose:

Ana Lourenco, MD, FSBI; Natalie Ward; Alexis LaCount

The planners, managers, and authors have the following identified relevant financial relationships:

Jennifer Harvey, MD, FSBI: Volpara, LLC, Shareholder; BHR Pharmaceuticals, Consulting Fee

The following author has no relevant financial relationships to disclose:

Cecilia Mercado, MD